AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly transferring manufacturing” across the Atlantic.
Related Posts
This internet stock is the best-performing name in Berkshire Hathaway’s portfolio this year, up 21%
VeriSign, which provides a dotcom domain registry service, has climbed 21% this year.
Stock futures drop on rising geopolitical risk as Israel-Iran attacks continue: Live updates
The three major indexes are coming off a losing week.
Super Micro Computer surges 20% after filing delayed financials by deadline
Super Micro also filed results for the first two quarters of the fiscal 2025 year and said that it has “regained compliance” with Nasdaq requirements.